Abstract
Methods
Cross-cultural adaptation was performed according to guidelines: translation, back translation, focus-group, and field test.
We performed validation with internal consistency by Cronbach’s alpha and construct validity by exploratory factor analysis
(EFA) with varimax rotation method. We compared each CTSQ domain between traditional Korean Medicine (TKM) and integrative
cancer therapy (ICT) of combining western and TKM by two-sample t test.
We performed validation with internal consistency by Cronbach’s alpha and construct validity by exploratory factor analysis
(EFA) with varimax rotation method. We compared each CTSQ domain between traditional Korean Medicine (TKM) and integrative
cancer therapy (ICT) of combining western and TKM by two-sample t test.
Results
Cross-cultural adaptation produced no major modifications in the items and domains. A total of 102 outpatients were participated.
Mean age was 51.9 ± 12.4. Most were stage 4 (74.4 %) cancer. Mean scores of ET, FSE, and SWT were 81.2 ± 15.7, 79.5 ± 22.9,
and 75.7 ± 14.8, respectively. Cronbach’s alpha of ET, FSE, and SWT were 0.86, 0.78, and 0.74, respectively. EFA loaded items
on the three domains, which is very close to that of the original CTSQ. ET and SWT was similar, but FSE was significantly
higher in TKM than ICT (87.5 ± 19.3 vs. 74.9 ± 23.5; p = 0.0054).
Mean age was 51.9 ± 12.4. Most were stage 4 (74.4 %) cancer. Mean scores of ET, FSE, and SWT were 81.2 ± 15.7, 79.5 ± 22.9,
and 75.7 ± 14.8, respectively. Cronbach’s alpha of ET, FSE, and SWT were 0.86, 0.78, and 0.74, respectively. EFA loaded items
on the three domains, which is very close to that of the original CTSQ. ET and SWT was similar, but FSE was significantly
higher in TKM than ICT (87.5 ± 19.3 vs. 74.9 ± 23.5; p = 0.0054).
Conclusions
Cross-cultural adaptation was successful, and the adapted Korean CTSQ demonstrated good internal consistency and construct
validity. Similar expectation and satisfaction was shown between the two types of therapy, but patient’s reported feelings
about side effects was significantly lower in patients receiving TKM than receiving ICT. Korean version of CTSQ can be used
to evaluate Korean cancer patient’s experiences receiving various cancer therapy types.
validity. Similar expectation and satisfaction was shown between the two types of therapy, but patient’s reported feelings
about side effects was significantly lower in patients receiving TKM than receiving ICT. Korean version of CTSQ can be used
to evaluate Korean cancer patient’s experiences receiving various cancer therapy types.
- Content Type Journal Article
- Category Brief Communication
- Pages 1-6
- DOI 10.1007/s11136-012-0164-0
- Authors
- So Jeong Park, Graduate School of East–West Medical Science, Kyung Hee University Hospital Global Campus, 1732 Deogyeong-daro, Giheung-gu, Gyeonggi-do, Yongin-si, 446-701 Republic of Korea
- Soo Min An, College of Nursing Science, Kyung Hee University, Seoul, Republic of Korea
- Se Hyun Kim, Graduate School of East–West Medical Science, Kyung Hee University Hospital Global Campus, 1732 Deogyeong-daro, Giheung-gu, Gyeonggi-do, Yongin-si, 446-701 Republic of Korea
- Journal Quality of Life Research
- Online ISSN 1573-2649
- Print ISSN 0962-9343